Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin-proteasome pathway

FASEB Journal

Volumn 18, Issue 2, 2004, Pages 272-279

  Stangl, Verena ^a   Lorenz, Mario ^a   Meiners, Silke ^a   Ludwig, Antje ^a   Bartsch, Cornelia ^a   Moobed, Minoo ^a   Vietzke, Angelika ^a   Kinkel, Hans Tilmann ^a   Baumann, Gert ^a   Stangl, Karl ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Endothelium; Inhibitors; Nitric oxide synthase; Proteasome; Vasodilation

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CALPAIN; CATHEPSIN; CELL EXTRACT; CYCLOHEXIMIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; METHIONINE DERIVATIVE; N ACETYLLEUCYLLEUCYLMETHIONINE; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN INHIBITOR; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTERY ENDOTHELIUM; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PULMONARY ARTERY; UPREGULATION; VASODILATATION;

ANIMALS; CATTLE; CYSTEINE ENDOPEPTIDASES; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; LEUPEPTINS; MALE; MULTIENZYME COMPLEXES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PROTEASOME ENDOPEPTIDASE COMPLEX; PULMONARY ARTERY; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS; UBIQUITIN; VASODILATION;

ANIMALIA; BOVINAE; EUKARYOTA;

EID: 10744223540     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.03-0054com     Document Type: Article

References (20)

1. Kojda, G., and Harrison, D. (1999) Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res. 43, 562-571
2. Oemar, B. S., Tschudi, M. R., Godoy, N., Brovkovich, V., Malinski, T., and Lüscher, T. F. (1998) Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97, 2494-2498
3. Zeiher, A. M., Drexler, H., Saurbier, B., and Just, H. (1993) Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J. Clin. Invest. 92, 652-662
4. Busse, R., and Fleming, I. (1996) Endothelial dysfunction in atherosclerosis. J. Vasc. Res. 33, 181-194
5. Treasure, C. B., Vita, J. A., Cox, D. A., Fish, R. D., Gordon, J. B., Mudge, G. H., Colucci, W. S., Sutton, M. G., Selwyn, A. P., Alexander, R. W., et al. (1990) Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 81, 772-779
6. Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., and Zeiher, A. M. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (London) 399, 601-605
7. Dimmeler, S., Dernbach, E., and Zeiher, M. (2000) Phosphorylation of the endothelial nitric oxide synthase at Ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett. 477, 258-262
8. Wu, K. K. (2002) Regulation of endothelial nitric oxide synthase activity and gene expression. Ann. N.Y. Acad. Sci. 962, 122-130
9. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. (1994) Inhibitors of the proteasome block degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771
10. Coux, O., Tanaka, K., and Goldberg, A. L. (1996) Structure, and functions of the 20S, 26S proteasomes. Annu. Rev. Biochem. 65, 801-847
11. Hershko, A., Ciechanover, A., and Varshavsky, A. (2002) The ubiquitin system. Nat. Med. 10, 1073-1082
12. Dschietzig, T., Richter, C., Pfannenschmidt, G., Bartsch, C., Laule, M., Baumann, G., and Stangl, K. (2001) Dexamethasone inhibits stimulation of pulmonary endothelins by proinflammatory cytokines: possible involvement of a nuclear factor KB dependent mechanism. Intensive Care Med. 27, 751-756
13. Searles, C. D., Miwa, Y., Harrison, D. G., and Ramasamy, S. (1999) Posttranscriptional regulation of endothelial nitric oxide synthase during cell growth. Circ. Res. 85, 588-595
14. Kumeda, S. I., Deguchi, A., Toi, M., Omura, S., and Umezawa, K. (1999) Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells. Anticancer Res. 19, 3961-3968
15. Li, H., Wallerath, T., and Förstermann, U. (2002) Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 7, 132-147
16. Ramet, M. E., Ramet, M., Lu, Q., Nickerson, M., Savolainen, M. J., Malzone, A., and Karas, R. H. (2003) High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life. J. Am. Coll. Cardiol. 41, 2288-2297
17. Ziegler, T., Silacci, P., Harrison, V. J., and Hayoz, D. (1998) Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. Hypertension 32, 351-355
18. Zhang, R., Min, W., and Sessa, W. C. (1995) Functional analysis of the human endothelial nitric oxide synthase promoter. SP1 and GATA factors are necessary for basal transcription in endothelial cells. J. Biol. Chem. 270, 15320-15326
19. Laufs, U., La Fata, V., Plutzki, L., and Liao, J. K. (1998) Upregulation of the endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97, 1129-1135
20. Salhab, W. A., and Shaul, P. W. (2000) Regulation of types I and III NOS in ovine uterine arteries by daily and acute estrogen exposure. Am. J. Physiol. 278, H2134-H2142